Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/9704721

Download in:

View as

General Info

PMID
9704721